Accolade
NasdaqGM:ACCD
$ 7,02
$0,00 (0,00%)
7,02 $
$0,00 (0,00%)
End-of-day quote: 04/08/2025

Accolade Stock Value

The current analyst rating for Accolade is sf_Data Unavailable.
-

Accolade Company Info

EPS Growth 5Y
38,22%
Market Cap
$0,58 B
Long-Term Debt
$0,21 B
Short Interest
0,00%
Quarterly earnings
04/25/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
2007
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Accolade’s Price Target has risen from $8,27 to $8,27 - a 0,00% increase.

Top growth stocks in the health care sector (5Y.)

What does Accolade do?

Accolade, Inc. (Accolade) provides an advocacy-led, nationwide care delivery service consisted of personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. Accolade enables the company's members to receive the right healthcare for their individual needs. The company calls it Personalized Healthcare. Accolade solutions are personal, data driven, and value based to provide a healthcare experience that h...
×